A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy
Epilepsy, Seizures
About this trial
This is an interventional treatment trial for Epilepsy focused on measuring Epilepsy, Seizures, Topiramate, Prophylaxis, Antiepileptic
Eligibility Criteria
Inclusion Criteria: Body weight of at least 30 kilograms New epilepsy diagnosis and at least one unprovoked seizure within 3 months before study entry No history of antiepileptic drug use or taking a single antiepileptic drug for no longer than 6 weeks Females must be sexually abstinent, surgically sterile, or using adequate birth control measures, and have a negative pregnancy test before study entry Exclusion Criteria: Patients who do not have epilepsy Have progressive or degenerative disorders (for example, certain hereditary conditions) Have a significant history (within last 2 years) of unstable medical diseases (heart, kidney, hormone, or liver diseases) Have mental retardation or other condition that could make interpretation of the study results difficult alcohol or drug abuse within the previous year